Tenax Therapeutics discloses ADAR1 Capital Management as beneficial owner in Form 3 filing

Reuters2026/08/24 21:51

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Tenax Therapeutics Form 3 disclosed ADAR1 Capital Management as a 10% owner, reporting 3,827,951 shares of common stock.
Holdings also included 59,073 pre-funded warrants exercisable at USD 0.01 per share.
Filing listed 31,096 warrants exercisable at USD 4.5 per share.
Ownership event date was Aug. 20, 2026; the filing was signed Aug. 24, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenax Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001940272-26-000016), on August 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Tenax Therapeutics discloses ADAR1 Capital Management as beneficial owner in Form 3 filing

You may also like

Crypto prices